Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current DebtOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Current Assets (2019 - 2020)

Goldenwell Biotech (GWLL) has disclosed Current Assets for 2 consecutive years, with $250544.0 as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Current Assets changed N/A year-over-year to $250544.0, compared with a TTM value of $250544.0 through Sep 2020, changed N/A, and an annual FY2019 reading of $246593.0, changed N/A over the prior year.
  • Current Assets was $250544.0 for Q3 2020 at Goldenwell Biotech, up from $246593.0 in the prior quarter.
  • Across five years, Current Assets topped out at $250544.0 in Q3 2020 and bottomed at $246593.0 in Q4 2019.